[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Safinamide Mesylate Market Insights, Forecast to 2029

November 2023 | 78 pages | ID: G5625E94B87BEN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Safinamide Mesylate, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Safinamide Mesylate, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Safinamide Mesylate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Safinamide Mesylate sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Safinamide Mesylate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Safinamide Mesylate sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Teva api, Jiudian Pharmaceutical and Apicore LLC, etc.

By Company
  • Teva api
  • Jiudian Pharmaceutical
  • Apicore LLC
Segment by Type
  • 99% Purity
  • Other
Segment by Application
  • Parkinson's Disease
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • US & Canada
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • China Taiwan
  • Southeast Asia
    • India
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Turkey
    • Israel
    • GCC Countries
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Safinamide Mesylate production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Safinamide Mesylate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Safinamide Mesylate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 9: China by type and by application sales and revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Safinamide Mesylate sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.
1 STUDY COVERAGE

1.1 Safinamide Mesylate Product Introduction
1.2 Market by Type
  1.2.1 Global Safinamide Mesylate Market Size by Type, 2018 VS 2022 VS 2029
  1.2.2 99% Purity
  1.2.3 Other
1.3 Market by Application
  1.3.1 Global Safinamide Mesylate Market Size by Application, 2018 VS 2022 VS 2029
  1.3.2 Parkinson's Disease
  1.3.3 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 GLOBAL SAFINAMIDE MESYLATE PRODUCTION

2.1 Global Safinamide Mesylate Production Capacity (2018-2029)
2.2 Global Safinamide Mesylate Production by Region: 2018 VS 2022 VS 2029
2.3 Global Safinamide Mesylate Production by Region
  2.3.1 Global Safinamide Mesylate Historic Production by Region (2018-2023)
  2.3.2 Global Safinamide Mesylate Forecasted Production by Region (2024-2029)
  2.3.3 Global Safinamide Mesylate Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan

3 EXECUTIVE SUMMARY

3.1 Global Safinamide Mesylate Revenue Estimates and Forecasts 2018-2029
3.2 Global Safinamide Mesylate Revenue by Region
  3.2.1 Global Safinamide Mesylate Revenue by Region: 2018 VS 2022 VS 2029
  3.2.2 Global Safinamide Mesylate Revenue by Region (2018-2023)
  3.2.3 Global Safinamide Mesylate Revenue by Region (2024-2029)
  3.2.4 Global Safinamide Mesylate Revenue Market Share by Region (2018-2029)
3.3 Global Safinamide Mesylate Sales Estimates and Forecasts 2018-2029
3.4 Global Safinamide Mesylate Sales by Region
  3.4.1 Global Safinamide Mesylate Sales by Region: 2018 VS 2022 VS 2029
  3.4.2 Global Safinamide Mesylate Sales by Region (2018-2023)
  3.4.3 Global Safinamide Mesylate Sales by Region (2024-2029)
  3.4.4 Global Safinamide Mesylate Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America

4 COMPETITION BY MANUFACTURES

4.1 Global Safinamide Mesylate Sales by Manufacturers
  4.1.1 Global Safinamide Mesylate Sales by Manufacturers (2018-2023)
  4.1.2 Global Safinamide Mesylate Sales Market Share by Manufacturers (2018-2023)
  4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Safinamide Mesylate in 2022
4.2 Global Safinamide Mesylate Revenue by Manufacturers
  4.2.1 Global Safinamide Mesylate Revenue by Manufacturers (2018-2023)
  4.2.2 Global Safinamide Mesylate Revenue Market Share by Manufacturers (2018-2023)
  4.2.3 Global Top 10 and Top 5 Companies by Safinamide Mesylate Revenue in 2022
4.3 Global Safinamide Mesylate Sales Price by Manufacturers
4.4 Global Key Players of Safinamide Mesylate, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
  4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  4.5.2 Global Safinamide Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Safinamide Mesylate, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Safinamide Mesylate, Product Offered and Application
4.8 Global Key Manufacturers of Safinamide Mesylate, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans

5 MARKET SIZE BY TYPE

5.1 Global Safinamide Mesylate Sales by Type
  5.1.1 Global Safinamide Mesylate Historical Sales by Type (2018-2023)
  5.1.2 Global Safinamide Mesylate Forecasted Sales by Type (2024-2029)
  5.1.3 Global Safinamide Mesylate Sales Market Share by Type (2018-2029)
5.2 Global Safinamide Mesylate Revenue by Type
  5.2.1 Global Safinamide Mesylate Historical Revenue by Type (2018-2023)
  5.2.2 Global Safinamide Mesylate Forecasted Revenue by Type (2024-2029)
  5.2.3 Global Safinamide Mesylate Revenue Market Share by Type (2018-2029)
5.3 Global Safinamide Mesylate Price by Type
  5.3.1 Global Safinamide Mesylate Price by Type (2018-2023)
  5.3.2 Global Safinamide Mesylate Price Forecast by Type (2024-2029)

6 MARKET SIZE BY APPLICATION

6.1 Global Safinamide Mesylate Sales by Application
  6.1.1 Global Safinamide Mesylate Historical Sales by Application (2018-2023)
  6.1.2 Global Safinamide Mesylate Forecasted Sales by Application (2024-2029)
  6.1.3 Global Safinamide Mesylate Sales Market Share by Application (2018-2029)
6.2 Global Safinamide Mesylate Revenue by Application
  6.2.1 Global Safinamide Mesylate Historical Revenue by Application (2018-2023)
  6.2.2 Global Safinamide Mesylate Forecasted Revenue by Application (2024-2029)
  6.2.3 Global Safinamide Mesylate Revenue Market Share by Application (2018-2029)
6.3 Global Safinamide Mesylate Price by Application
  6.3.1 Global Safinamide Mesylate Price by Application (2018-2023)
  6.3.2 Global Safinamide Mesylate Price Forecast by Application (2024-2029)

7 US & CANADA

7.1 US & Canada Safinamide Mesylate Market Size by Type
  7.1.1 US & Canada Safinamide Mesylate Sales by Type (2018-2029)
  7.1.2 US & Canada Safinamide Mesylate Revenue by Type (2018-2029)
7.2 US & Canada Safinamide Mesylate Market Size by Application
  7.2.1 US & Canada Safinamide Mesylate Sales by Application (2018-2029)
  7.2.2 US & Canada Safinamide Mesylate Revenue by Application (2018-2029)
7.3 US & Canada Safinamide Mesylate Sales by Country
  7.3.1 US & Canada Safinamide Mesylate Revenue by Country: 2018 VS 2022 VS 2029
  7.3.2 US & Canada Safinamide Mesylate Sales by Country (2018-2029)
  7.3.3 US & Canada Safinamide Mesylate Revenue by Country (2018-2029)
  7.3.4 United States
  7.3.5 Canada

8 EUROPE

8.1 Europe Safinamide Mesylate Market Size by Type
  8.1.1 Europe Safinamide Mesylate Sales by Type (2018-2029)
  8.1.2 Europe Safinamide Mesylate Revenue by Type (2018-2029)
8.2 Europe Safinamide Mesylate Market Size by Application
  8.2.1 Europe Safinamide Mesylate Sales by Application (2018-2029)
  8.2.2 Europe Safinamide Mesylate Revenue by Application (2018-2029)
8.3 Europe Safinamide Mesylate Sales by Country
  8.3.1 Europe Safinamide Mesylate Revenue by Country: 2018 VS 2022 VS 2029
  8.3.2 Europe Safinamide Mesylate Sales by Country (2018-2029)
  8.3.3 Europe Safinamide Mesylate Revenue by Country (2018-2029)
  8.3.4 Germany
  8.3.5 France
  8.3.6 U.K.
  8.3.7 Italy
  8.3.8 Russia

9 CHINA

9.1 China Safinamide Mesylate Market Size by Type
  9.1.1 China Safinamide Mesylate Sales by Type (2018-2029)
  9.1.2 China Safinamide Mesylate Revenue by Type (2018-2029)
9.2 China Safinamide Mesylate Market Size by Application
  9.2.1 China Safinamide Mesylate Sales by Application (2018-2029)
  9.2.2 China Safinamide Mesylate Revenue by Application (2018-2029)

10 ASIA (EXCLUDING CHINA)

10.1 Asia Safinamide Mesylate Market Size by Type
  10.1.1 Asia Safinamide Mesylate Sales by Type (2018-2029)
  10.1.2 Asia Safinamide Mesylate Revenue by Type (2018-2029)
10.2 Asia Safinamide Mesylate Market Size by Application
  10.2.1 Asia Safinamide Mesylate Sales by Application (2018-2029)
  10.2.2 Asia Safinamide Mesylate Revenue by Application (2018-2029)
10.3 Asia Safinamide Mesylate Sales by Region
  10.3.1 Asia Safinamide Mesylate Revenue by Region: 2018 VS 2022 VS 2029
  10.3.2 Asia Safinamide Mesylate Revenue by Region (2018-2029)
  10.3.3 Asia Safinamide Mesylate Sales by Region (2018-2029)
  10.3.4 Japan
  10.3.5 South Korea
  10.3.6 China Taiwan
  10.3.7 Southeast Asia
  10.3.8 India

11 MIDDLE EAST, AFRICA AND LATIN AMERICA

11.1 Middle East, Africa and Latin America Safinamide Mesylate Market Size by Type
  11.1.1 Middle East, Africa and Latin America Safinamide Mesylate Sales by Type (2018-2029)
  11.1.2 Middle East, Africa and Latin America Safinamide Mesylate Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Safinamide Mesylate Market Size by Application
  11.2.1 Middle East, Africa and Latin America Safinamide Mesylate Sales by Application (2018-2029)
  11.2.2 Middle East, Africa and Latin America Safinamide Mesylate Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Safinamide Mesylate Sales by Country
  11.3.1 Middle East, Africa and Latin America Safinamide Mesylate Revenue by Country: 2018 VS 2022 VS 2029
  11.3.2 Middle East, Africa and Latin America Safinamide Mesylate Revenue by Country (2018-2029)
  11.3.3 Middle East, Africa and Latin America Safinamide Mesylate Sales by Country (2018-2029)
  11.3.4 Brazil
  11.3.5 Mexico
  11.3.6 Turkey
  11.3.7 Israel
  11.3.8 GCC Countries

12 CORPORATE PROFILES

12.1 Teva api
  12.1.1 Teva api Company Information
  12.1.2 Teva api Overview
  12.1.3 Teva api Safinamide Mesylate Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.1.4 Teva api Safinamide Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
  12.1.5 Teva api Recent Developments
12.2 Jiudian Pharmaceutical
  12.2.1 Jiudian Pharmaceutical Company Information
  12.2.2 Jiudian Pharmaceutical Overview
  12.2.3 Jiudian Pharmaceutical Safinamide Mesylate Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.2.4 Jiudian Pharmaceutical Safinamide Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
  12.2.5 Jiudian Pharmaceutical Recent Developments
12.3 Apicore LLC
  12.3.1 Apicore LLC Company Information
  12.3.2 Apicore LLC Overview
  12.3.3 Apicore LLC Safinamide Mesylate Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.3.4 Apicore LLC Safinamide Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
  12.3.5 Apicore LLC Recent Developments

13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

13.1 Safinamide Mesylate Industry Chain Analysis
13.2 Safinamide Mesylate Key Raw Materials
  13.2.1 Key Raw Materials
  13.2.2 Raw Materials Key Suppliers
13.3 Safinamide Mesylate Production Mode & Process
13.4 Safinamide Mesylate Sales and Marketing
  13.4.1 Safinamide Mesylate Sales Channels
  13.4.2 Safinamide Mesylate Distributors
13.5 Safinamide Mesylate Customers

14 SAFINAMIDE MESYLATE MARKET DYNAMICS

14.1 Safinamide Mesylate Industry Trends
14.2 Safinamide Mesylate Market Drivers
14.3 Safinamide Mesylate Market Challenges
14.4 Safinamide Mesylate Market Restraints

15 KEY FINDING IN THE GLOBAL SAFINAMIDE MESYLATE STUDY


16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Safinamide Mesylate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 99% Purity
Table 3. Major Manufacturers of Other
Table 4. Global Safinamide Mesylate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Safinamide Mesylate Production by Region: 2018 VS 2022 VS 2029 (Kiloton)
Table 6. Global Safinamide Mesylate Production by Region (2018-2023) & (Kiloton)
Table 7. Global Safinamide Mesylate Production by Region (2024-2029) & (Kiloton)
Table 8. Global Safinamide Mesylate Production Market Share by Region (2018-2023)
Table 9. Global Safinamide Mesylate Production Market Share by Region (2024-2029)
Table 10. Global Safinamide Mesylate Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Safinamide Mesylate Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global Safinamide Mesylate Revenue by Region (2024-2029) & (US$ Million)
Table 13. Global Safinamide Mesylate Revenue Market Share by Region (2018-2023)
Table 14. Global Safinamide Mesylate Revenue Market Share by Region (2024-2029)
Table 15. Global Safinamide Mesylate Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Safinamide Mesylate Sales by Region (2018-2023) & (Kiloton)
Table 17. Global Safinamide Mesylate Sales by Region (2024-2029) & (Kiloton)
Table 18. Global Safinamide Mesylate Sales Market Share by Region (2018-2023)
Table 19. Global Safinamide Mesylate Sales Market Share by Region (2024-2029)
Table 20. Global Safinamide Mesylate Sales by Manufacturers (2018-2023) & (Kiloton)
Table 21. Global Safinamide Mesylate Sales Share by Manufacturers (2018-2023)
Table 22. Global Safinamide Mesylate Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global Safinamide Mesylate Revenue Share by Manufacturers (2018-2023)
Table 24. Safinamide Mesylate Price by Manufacturers 2018-2023 (US$/Ton)
Table 25. Global Key Players of Safinamide Mesylate, Industry Ranking, 2021 VS 2022 VS 2023
Table 26. Global Safinamide Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Safinamide Mesylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safinamide Mesylate as of 2022)
Table 28. Global Key Manufacturers of Safinamide Mesylate, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Safinamide Mesylate, Product Offered and Application
Table 30. Global Key Manufacturers of Safinamide Mesylate, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Safinamide Mesylate Sales by Type (2018-2023) & (Kiloton)
Table 33. Global Safinamide Mesylate Sales by Type (2024-2029) & (Kiloton)
Table 34. Global Safinamide Mesylate Sales Share by Type (2018-2023)
Table 35. Global Safinamide Mesylate Sales Share by Type (2024-2029)
Table 36. Global Safinamide Mesylate Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global Safinamide Mesylate Revenue by Type (2024-2029) & (US$ Million)
Table 38. Global Safinamide Mesylate Revenue Share by Type (2018-2023)
Table 39. Global Safinamide Mesylate Revenue Share by Type (2024-2029)
Table 40. Safinamide Mesylate Price by Type (2018-2023) & (US$/Ton)
Table 41. Global Safinamide Mesylate Price Forecast by Type (2024-2029) & (US$/Ton)
Table 42. Global Safinamide Mesylate Sales by Application (2018-2023) & (Kiloton)
Table 43. Global Safinamide Mesylate Sales by Application (2024-2029) & (Kiloton)
Table 44. Global Safinamide Mesylate Sales Share by Application (2018-2023)
Table 45. Global Safinamide Mesylate Sales Share by Application (2024-2029)
Table 46. Global Safinamide Mesylate Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Safinamide Mesylate Revenue by Application (2024-2029) & (US$ Million)
Table 48. Global Safinamide Mesylate Revenue Share by Application (2018-2023)
Table 49. Global Safinamide Mesylate Revenue Share by Application (2024-2029)
Table 50. Safinamide Mesylate Price by Application (2018-2023) & (US$/Ton)
Table 51. Global Safinamide Mesylate Price Forecast by Application (2024-2029) & (US$/Ton)
Table 52. US & Canada Safinamide Mesylate Sales by Type (2018-2023) & (Kiloton)
Table 53. US & Canada Safinamide Mesylate Sales by Type (2024-2029) & (Kiloton)
Table 54. US & Canada Safinamide Mesylate Revenue by Type (2018-2023) & (US$ Million)
Table 55. US & Canada Safinamide Mesylate Revenue by Type (2024-2029) & (US$ Million)
Table 56. US & Canada Safinamide Mesylate Sales by Application (2018-2023) & (Kiloton)
Table 57. US & Canada Safinamide Mesylate Sales by Application (2024-2029) & (Kiloton)
Table 58. US & Canada Safinamide Mesylate Revenue by Application (2018-2023) & (US$ Million)
Table 59. US & Canada Safinamide Mesylate Revenue by Application (2024-2029) & (US$ Million)
Table 60. US & Canada Safinamide Mesylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. US & Canada Safinamide Mesylate Revenue by Country (2018-2023) & (US$ Million)
Table 62. US & Canada Safinamide Mesylate Revenue by Country (2024-2029) & (US$ Million)
Table 63. US & Canada Safinamide Mesylate Sales by Country (2018-2023) & (Kiloton)
Table 64. US & Canada Safinamide Mesylate Sales by Country (2024-2029) & (Kiloton)
Table 65. Europe Safinamide Mesylate Sales by Type (2018-2023) & (Kiloton)
Table 66. Europe Safinamide Mesylate Sales by Type (2024-2029) & (Kiloton)
Table 67. Europe Safinamide Mesylate Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Safinamide Mesylate Revenue by Type (2024-2029) & (US$ Million)
Table 69. Europe Safinamide Mesylate Sales by Application (2018-2023) & (Kiloton)
Table 70. Europe Safinamide Mesylate Sales by Application (2024-2029) & (Kiloton)
Table 71. Europe Safinamide Mesylate Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Safinamide Mesylate Revenue by Application (2024-2029) & (US$ Million)
Table 73. Europe Safinamide Mesylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 74. Europe Safinamide Mesylate Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Safinamide Mesylate Revenue by Country (2024-2029) & (US$ Million)
Table 76. Europe Safinamide Mesylate Sales by Country (2018-2023) & (Kiloton)
Table 77. Europe Safinamide Mesylate Sales by Country (2024-2029) & (Kiloton)
Table 78. China Safinamide Mesylate Sales by Type (2018-2023) & (Kiloton)
Table 79. China Safinamide Mesylate Sales by Type (2024-2029) & (Kiloton)
Table 80. China Safinamide Mesylate Revenue by Type (2018-2023) & (US$ Million)
Table 81. China Safinamide Mesylate Revenue by Type (2024-2029) & (US$ Million)
Table 82. China Safinamide Mesylate Sales by Application (2018-2023) & (Kiloton)
Table 83. China Safinamide Mesylate Sales by Application (2024-2029) & (Kiloton)
Table 84. China Safinamide Mesylate Revenue by Application (2018-2023) & (US$ Million)
Table 85. China Safinamide Mesylate Revenue by Application (2024-2029) & (US$ Million)
Table 86. Asia Safinamide Mesylate Sales by Type (2018-2023) & (Kiloton)
Table 87. Asia Safinamide Mesylate Sales by Type (2024-2029) & (Kiloton)
Table 88. Asia Safinamide Mesylate Revenue by Type (2018-2023) & (US$ Million)
Table 89. Asia Safinamide Mesylate Revenue by Type (2024-2029) & (US$ Million)
Table 90. Asia Safinamide Mesylate Sales by Application (2018-2023) & (Kiloton)
Table 91. Asia Safinamide Mesylate Sales by Application (2024-2029) & (Kiloton)
Table 92. Asia Safinamide Mesylate Revenue by Application (2018-2023) & (US$ Million)
Table 93. Asia Safinamide Mesylate Revenue by Application (2024-2029) & (US$ Million)
Table 94. Asia Safinamide Mesylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 95. Asia Safinamide Mesylate Revenue by Region (2018-2023) & (US$ Million)
Table 96. Asia Safinamide Mesylate Revenue by Region (2024-2029) & (US$ Million)
Table 97. Asia Safinamide Mesylate Sales by Region (2018-2023) & (Kiloton)
Table 98. Asia Safinamide Mesylate Sales by Region (2024-2029) & (Kiloton)
Table 99. Middle East, Africa and Latin America Safinamide Mesylate Sales by Type (2018-2023) & (Kiloton)
Table 100. Middle East, Africa and Latin America Safinamide Mesylate Sales by Type (2024-2029) & (Kiloton)
Table 101. Middle East, Africa and Latin America Safinamide Mesylate Revenue by Type (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Safinamide Mesylate Revenue by Type (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Safinamide Mesylate Sales by Application (2018-2023) & (Kiloton)
Table 104. Middle East, Africa and Latin America Safinamide Mesylate Sales by Application (2024-2029) & (Kiloton)
Table 105. Middle East, Africa and Latin America Safinamide Mesylate Revenue by Application (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Safinamide Mesylate Revenue by Application (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Safinamide Mesylate Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 108. Middle East, Africa and Latin America Safinamide Mesylate Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Safinamide Mesylate Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Safinamide Mesylate Sales by Country (2018-2023) & (Kiloton)
Table 111. Middle East, Africa and Latin America Safinamide Mesylate Sales by Country (2024-2029) & (Kiloton)
Table 112. Teva api Company Information
Table 113. Teva api Description and Major Businesses
Table 114. Teva api Safinamide Mesylate Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 115. Teva api Safinamide Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva api Recent Development
Table 117. Jiudian Pharmaceutical Company Information
Table 118. Jiudian Pharmaceutical Description and Major Businesses
Table 119. Jiudian Pharmaceutical Safinamide Mesylate Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 120. Jiudian Pharmaceutical Safinamide Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Jiudian Pharmaceutical Recent Development
Table 122. Apicore LLC Company Information
Table 123. Apicore LLC Description and Major Businesses
Table 124. Apicore LLC Safinamide Mesylate Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 125. Apicore LLC Safinamide Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Apicore LLC Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Safinamide Mesylate Distributors List
Table 130. Safinamide Mesylate Customers List
Table 131. Safinamide Mesylate Market Trends
Table 132. Safinamide Mesylate Market Drivers
Table 133. Safinamide Mesylate Market Challenges
Table 134. Safinamide Mesylate Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Safinamide Mesylate Product Picture
Figure 2. Global Safinamide Mesylate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Safinamide Mesylate Market Share by Type in 2022 & 2029
Figure 4. 99% Purity Product Picture
Figure 5. Other Product Picture
Figure 6. Global Safinamide Mesylate Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Safinamide Mesylate Market Share by Application in 2022 & 2029
Figure 8. Parkinson's Disease
Figure 9. Other
Figure 10. Safinamide Mesylate Report Years Considered
Figure 11. Global Safinamide Mesylate Capacity, Production and Utilization (2018-2029) & (Kiloton)
Figure 12. Global Safinamide Mesylate Production Market Share by Region in Percentage: 2022 Versus 2029
Figure 13. Global Safinamide Mesylate Production Market Share by Region (2018-2029)
Figure 14. Safinamide Mesylate Production Growth Rate in North America (2018-2029) & (Kiloton)
Figure 15. Safinamide Mesylate Production Growth Rate in Europe (2018-2029) & (Kiloton)
Figure 16. Safinamide Mesylate Production Growth Rate in China (2018-2029) & (Kiloton)
Figure 17. Safinamide Mesylate Production Growth Rate in Japan (2018-2029) & (Kiloton)
Figure 18. Global Safinamide Mesylate Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Safinamide Mesylate Revenue 2018-2029 (US$ Million)
Figure 20. Global Safinamide Mesylate Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 21. Global Safinamide Mesylate Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 22. Global Safinamide Mesylate Revenue Market Share by Region (2018-2029)
Figure 23. Global Safinamide Mesylate Sales 2018-2029 ((Kiloton)
Figure 24. Global Safinamide Mesylate Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (Kiloton)
Figure 25. Global Safinamide Mesylate Sales Market Share by Region (2018-2029)
Figure 26. US & Canada Safinamide Mesylate Sales YoY (2018-2029) & (Kiloton)
Figure 27. US & Canada Safinamide Mesylate Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Europe Safinamide Mesylate Sales YoY (2018-2029) & (Kiloton)
Figure 29. Europe Safinamide Mesylate Revenue YoY (2018-2029) & (US$ Million)
Figure 30. China Safinamide Mesylate Sales YoY (2018-2029) & (Kiloton)
Figure 31. China Safinamide Mesylate Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Asia (excluding China) Safinamide Mesylate Sales YoY (2018-2029) & (Kiloton)
Figure 33. Asia (excluding China) Safinamide Mesylate Revenue YoY (2018-2029) & (US$ Million)
Figure 34. Middle East, Africa and Latin America Safinamide Mesylate Sales YoY (2018-2029) & (Kiloton)
Figure 35. Middle East, Africa and Latin America Safinamide Mesylate Revenue YoY (2018-2029) & (US$ Million)
Figure 36. The Safinamide Mesylate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 37. The Top 5 and 10 Largest Manufacturers of Safinamide Mesylate in the World: Market Share by Safinamide Mesylate Revenue in 2022
Figure 38. Global Safinamide Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 39. Global Safinamide Mesylate Sales Market Share by Type (2018-2029)
Figure 40. Global Safinamide Mesylate Revenue Market Share by Type (2018-2029)
Figure 41. Global Safinamide Mesylate Sales Market Share by Application (2018-2029)
Figure 42. Global Safinamide Mesylate Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Safinamide Mesylate Sales Market Share by Type (2018-2029)
Figure 44. US & Canada Safinamide Mesylate Revenue Market Share by Type (2018-2029)
Figure 45. US & Canada Safinamide Mesylate Sales Market Share by Application (2018-2029)
Figure 46. US & Canada Safinamide Mesylate Revenue Market Share by Application (2018-2029)
Figure 47. US & Canada Safinamide Mesylate Revenue Share by Country (2018-2029)
Figure 48. US & Canada Safinamide Mesylate Sales Share by Country (2018-2029)
Figure 49. U.S. Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 50. Canada Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 51. Europe Safinamide Mesylate Sales Market Share by Type (2018-2029)
Figure 52. Europe Safinamide Mesylate Revenue Market Share by Type (2018-2029)
Figure 53. Europe Safinamide Mesylate Sales Market Share by Application (2018-2029)
Figure 54. Europe Safinamide Mesylate Revenue Market Share by Application (2018-2029)
Figure 55. Europe Safinamide Mesylate Revenue Share by Country (2018-2029)
Figure 56. Europe Safinamide Mesylate Sales Share by Country (2018-2029)
Figure 57. Germany Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 58. France Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 59. U.K. Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 60. Italy Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 61. Russia Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 62. China Safinamide Mesylate Sales Market Share by Type (2018-2029)
Figure 63. China Safinamide Mesylate Revenue Market Share by Type (2018-2029)
Figure 64. China Safinamide Mesylate Sales Market Share by Application (2018-2029)
Figure 65. China Safinamide Mesylate Revenue Market Share by Application (2018-2029)
Figure 66. Asia Safinamide Mesylate Sales Market Share by Type (2018-2029)
Figure 67. Asia Safinamide Mesylate Revenue Market Share by Type (2018-2029)
Figure 68. Asia Safinamide Mesylate Sales Market Share by Application (2018-2029)
Figure 69. Asia Safinamide Mesylate Revenue Market Share by Application (2018-2029)
Figure 70. Asia Safinamide Mesylate Revenue Share by Region (2018-2029)
Figure 71. Asia Safinamide Mesylate Sales Share by Region (2018-2029)
Figure 72. Japan Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 73. South Korea Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 74. China Taiwan Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 75. Southeast Asia Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 76. India Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Safinamide Mesylate Sales Market Share by Type (2018-2029)
Figure 78. Middle East, Africa and Latin America Safinamide Mesylate Revenue Market Share by Type (2018-2029)
Figure 79. Middle East, Africa and Latin America Safinamide Mesylate Sales Market Share by Application (2018-2029)
Figure 80. Middle East, Africa and Latin America Safinamide Mesylate Revenue Market Share by Application (2018-2029)
Figure 81. Middle East, Africa and Latin America Safinamide Mesylate Revenue Share by Country (2018-2029)
Figure 82. Middle East, Africa and Latin America Safinamide Mesylate Sales Share by Country (2018-2029)
Figure 83. Brazil Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 84. Mexico Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 85. Turkey Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 86. Israel Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 87. GCC Countries Safinamide Mesylate Revenue (2018-2029) & (US$ Million)
Figure 88. Safinamide Mesylate Value Chain
Figure 89. Safinamide Mesylate Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed


More Publications